Navigation Links
Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association
Date:11/10/2008

New Data Presented at the Meeting Report the Use of Haptoglobin Typing to Predict Cardiovascular Risk, and Benefit From Tight Glycemic Control in Diabetics

MONTVALE, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) today announced at the Annual Scientific Sessions of the American Heart Association, underway in New Orleans, that a new clinical test to determine haptoglobin (Hp) genotype utilizing intellectual property licensed from Synvista is now available. Knowledge of Hp genotype may help physicians to assess cardiovascular risk and guide treatment choices in their patients with diabetes. Several presentations relating to the Company's technology are being delivered during the Scientific Sessions, including one showing that older individuals with diabetes mellitus and the Hp2-2 genotype (Hp2-2 Diabetes) demonstrate a significantly higher mortality rate from cardiovascular disease than those who do not have the Hp 2-2 genotype; and another demonstrating that tight glycemic control reduces the incidence of heart attack (myocardial infarction - MI) only in Hp2-2 Diabetes.

The test, which was developed and validated by ARUP Laboratories, will be performed under a license agreement with Synvista in ARUP's CLIA-certified laboratory. In addition, Synvista has developed its own test utilizing different technology than ARUP which it intends to market as a diagnostic kit after submitting a 510(k) to, and obtaining clearance from, the U.S. Food and Drug Administration (FDA).

"We are extremely pleased that our intellectual property will have a role in making personalized medicine a reality," said Noah Berkowitz, M.D., President and CEO of Synvista Therapeutics. "We believe that the ease of use of o
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Synvista Therapeutics Posts Letter to Stockholders on Web Site
2. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
3. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
4. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
6. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
7. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
8. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
9. Synvista Therapeutics to be Featured on Wallst.net
10. Synvista Therapeutics to Present at the BIO InvestorForum 2007
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Frederick, MD (PRWEB) November 21, 2014 ... sample management solutions provider, has released Limfinity® version ... more installation projects of Limfinity® than ever in ... majority configuration and minority framework enhancement. Limfinity® version ... goes far above and beyond bug fixes! , ...
(Date:11/22/2014)... , November 21, 2014   ... als Chief Commercial Officer zu KLOX    ... Unternehmensentwicklung und Chief Financial Officer bestellt    ... der Vermarktung seines jüngst zugelassenen Behandlungssystems zur Wundheilung zu ... bzw. das "Unternehmen") ist sehr erfreut, die folgenden personellen ...
(Date:11/21/2014)... (PRWEB) November 20, 2014 Author Matthew ... Walk to the Other Side” published as a ... Finalist in the “Fiction: Short Story” category of the ... Keen, President and CEO of USA Book News, said ... and independent publishers, including Simon & Schuster, Penguin, John ...
(Date:11/21/2014)... CA (PRWEB) November 21, 2014 Why ... that makes Albert Einstein so instantly recognizable? Why have ... physicist, mathematician, astronomer and author Hilton Ratcliffe seeks out ... have nothing at all to do with science. In ... Harbor Publishing , November 21, 2014), Ratcliffe puts it ...
Breaking Biology Technology:RURO Announces Limfinity® version 5.1.4 2KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 2Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 3Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 4“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4
... Mass., Aug. 6 Repligen Corporation (Nasdaq: RGEN ) ... June 30, 2009. Total revenue for the quarter was $5,061,000 ... fiscal year 2009. The prior year results were favorably impacted ... royalties on the U.S. sales of Orencia(R) prior to the April ...
... RICHLAND, Wash. -- To use hydrogen as a clean energy ... molecule, rather than compressing the gas into a tank. A ... out of a molecule requires a catalyst. Now, researchers reveal ... step toward designing catalysts for use in hydrogen energy applications ...
... Exciton Technologies Inc. today announced that the Company ... and Drug Administration (FDA) to market exSALT(TM) SD7 ... coating technology utilizing silver oxysalts as the active ... effort and a strong belief in our product," ...
Cached Biology Technology:Repligen Reports First Quarter Fiscal Year 2010 Financial Results 2Repligen Reports First Quarter Fiscal Year 2010 Financial Results 3Repligen Reports First Quarter Fiscal Year 2010 Financial Results 4Repligen Reports First Quarter Fiscal Year 2010 Financial Results 5Repligen Reports First Quarter Fiscal Year 2010 Financial Results 6Repligen Reports First Quarter Fiscal Year 2010 Financial Results 7New clues about a hydrogen fuel catalyst 2New clues about a hydrogen fuel catalyst 3Exciton Technologies receives FDA approval to market exSALT(TM) 2Exciton Technologies receives FDA approval to market exSALT(TM) 3
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug ... U.S. regulatory agencies will speak and at least seven more ... Conference at the Omni Shoreham Hotel in Washington ... once again to have significant support from the regulatory agencies ... Europe in our effort to help advance ...
(Date:11/11/2014)... Nov. 11, 2014  Forensicon, Inc., a ... pleased to announce the promotion of Yaniv Schiff ... Digital Forensics. In Schiff,s new role as Director, he ... of digital forensics examiners and provide leadership within the ... - http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined ...
(Date:11/7/2014)... , November 6, 2014 Leading ... for better mobile security revolutionizing online transactions.  Companies in focus ... Holdings Ltd. (NYSE: BABA ), Google Inc. (NASDAQ: ... ), eBay Inc. (NASDAQ: EBAY ) and MasterCard ... NXTD and NXTDW), a biometric authentication company focused on ...
Breaking Biology News(10 mins):FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6
... wrong place to protect vulnerable coral reefs from the effects ... Now the team led jointly by Newcastle University and ... action is needed to prevent the collapse of this important ... PLoS ONE , is the largest study of its ...
... science" breakthrough by Queen,s University researchers into regulating a ... will help prevent heart attacks and strokes. ... the study focuses on the effects of Viagra ... to treat pulmonary hypertension. The team,s findings will ...
... in the Olympics, but scientists have raced cane toads in ... to invade Melbourne, Adelaide or Hobart and are unlikely to ... According to research by Dr Michael Kearney, from the ... from Australia and the USA, the cane toad,s march will ...
Cached Biology News:No-take zones offer no boost for bleached reefs 2Study points to potential new use for Viagra 2Racing cane toads reveals they get cold feet on Southern Australia invasion 2Racing cane toads reveals they get cold feet on Southern Australia invasion 3
... Mouse polyclonal antibody raised ... Immunogen: ... 646 a.a) partial recombinant protein ... Accession Number: NM_006842 ...
Mouse monoclonal antibody to UGT2B10 - UDP glucuronosyltransferase 2 family, polypeptide B10...
... kit is a sample preparation kit for ... removal of detergents, phenolic compounds, salts, and ... dilute samples. The kit procedure involves a ... tissue or cells, plant leaves, E. coli, ...
... Factor XIII in both reduced and non-reduced ... XIII B-chain or human Factor XII. Factor XIII ... composed of two subunits. Factor XIII-A is the ... 160kDa. Factor XIII is present in plasma as ...
Biology Products: